Glenmark Pharmaceuticals says it “expects to be one of the first generics” for a generic version of Boehringer Ingelheim’s Spiriva Handihaler (tiotropium bromide) dry-powder inhaler, and “should be launching anytime soon.”
The Indian firm, which continues to take steps to build its global respiratory franchise, in-licensed the product more than three...




